Reducing pill burden and helping with medication awareness to improve adherence.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

37 citing papers in PubMed, 2 syntheses or guidelines pooled it.

1. Poor glycemic control and its predictors among people living with diabetes in low- and middle-income countries: a systematic review and meta-analysis.BMC public health · 2025
   Pooled it
2. Adherence to iron-folic acid supplementation among pregnant women in Ethiopia: a systematic review and meta-analysis.BMC pregnancy and childbirth · 2020
   Pooled it
3. Is the Capsaicin 179 mg (8% w/w) Cutaneous Patch an Appropriate Treatment Option for Older Patients with Peripheral Neuropathic Pain?Journal of pain research · 2024
   Trial
4. Ticagrelor or prasugrel in patients with acute coronary syndrome with off-hour versus on-hour presentation: a subgroup analysis of the ISAR-REACT 5 trial.Clinical research in cardiology : official journal of the German Cardiac Society · 2023
   Trial
5. EVG/COBI/FTC/TAF Bioequivalence Comparing Whole Tablets with Tablets Dissolved in Tap Water.AIDS research and human retroviruses · 2023
   Trial
6. Long-term safety and efficacy of opicapone in Japanese Parkinson's patients with motor fluctuations.Journal of neural transmission (Vienna, Austria : 1996) · 2021
   Trial
7. A novel once-daily fixed-dose combination of memantine extended release and donepezil for the treatment of moderate to severe Alzheimer's disease: two phase I studies in healthy volunteers.Clinical drug investigation · 2015
   Trial
8. Experimentally Derived Hansen Solubility Parameters as a Screening Tool for the Formulation of Amorphous Solid Dispersions.ACS omega · 2026
   Article
9. Health Systems and Self-Reported Medication Adherence in Patients with Hypertension: A cross-sectional comparison of Jamaica and Colombia.Research square · 2025
   Article
10. Patients' acceptability, adherence and satisfaction on the modified shorter all-oral multidrug-resistant tuberculosis regimen: a two-phase cross-sectional study in Tanzania.BMJ open · 2025
    Observational
11. Bioequivalence Study of Two Oral Methocarbamol Formulations in Healthy Subjects Under Fasting Conditions: A Randomized, Open-Label, Crossover Clinical Trial.Pharmaceuticals (Basel, Switzerland) · 2025
    Article
12. Perspectives of postpartum women on intermittent presumptive treatment in Uganda: implications for malaria prevention: a qualitative study.Malaria journal · 2024
    Article
13. Assessing the Pharmacotherapy and Clinical Outcomes After Deep Brain Stimulation for Treatment-Refractory Obsessive-Compulsive Disorder: A Case-Cohort Study.Journal of clinical medicine · 2024
    Article
14. Complex Emulsions as an Innovative Pharmaceutical Dosage form in Addressing the Issues of Multi-Drug Therapy and Polypharmacy Challenges.Pharmaceutics · 2024
    Review
15. Retrospective review of medicine utilization for noncommunicable diseases in three public sector pharmacies in Jamaica.Revista panamericana de salud publica = Pan American journal of public health · 2024
    Article
16. [Polypharmacy in acute and chronic kidney diseases].Innere Medizin (Heidelberg, Germany) · 2024
    Review
17. Drug Release from Surfactant-Containing Amorphous Solid Dispersions: Mechanism and Role of Surfactant in Release Enhancement.Pharmaceutical research · 2023
    Article
18. Pill-burden and its association with treatment burden among patients with advanced stages of chronic kidney disease.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Article
19. The association between polypharmacy and health-related quality of life among non-dialysis chronic kidney disease patients.PloS one · 2023
    Article
20. Optimizing the pipeline of multipurpose prevention technologies: opportunities across women's reproductive lifespans.Frontiers in reproductive health · 2023
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.